| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/10/2003 | WO2003028741A1 Composition of hypochlorous acid and its applications |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/10/2003 | US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 04/09/2003 | EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 04/09/2003 | EP1299039A1 Use of a liquid medicament in surgical high pressure liquid jet devices |
| 04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003026744A1 The use of epothilones and analogs in conjunction with ophthalmic surgery |
| 04/03/2003 | WO2002092016A3 Therapeutic use of rank antagonists |
| 04/03/2003 | WO2002022166A9 Tweak receptor agonists as anti-angiogenic agents |
| 04/03/2003 | US20030064958 Pharmaceutical compositions and methods relating to fucans |
| 04/03/2003 | US20030064114 For vasodilatation and inhibition of transplant rejection |
| 04/02/2003 | EP1297116A2 Method for isolating and purifying a protein and resulting protein |
| 04/02/2003 | EP1296650A2 Methods and compositions for treating pain of the mucous membrane |
| 04/02/2003 | EP0927053B1 Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 03/27/2003 | WO2002094019A9 Highly purified antiendotoxin compound |
| 03/27/2003 | US20030060481 The use of scopolamine salts |
| 03/26/2003 | EP1294765A2 Il-17 molecules and uses thereof |
| 03/26/2003 | EP1294395A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 03/26/2003 | EP0847240B1 Novel embolizing compositions |
| 03/20/2003 | WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 03/20/2003 | WO2002030444A3 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 03/20/2003 | US20030055021 Compounds for the treatment of ischemia |
| 03/20/2003 | US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy |
| 03/19/2003 | EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/19/2003 | EP1292340A1 Transfection system |
| 03/19/2003 | EP1292324A2 Critical illness neuropathy |
| 03/18/2003 | US6534510 Anticoagulants |
| 03/13/2003 | WO2001088103A3 Compositions and methods for tissue dedifferentiation and regeneration |
| 03/13/2003 | US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease |
| 03/12/2003 | EP1291039A1 Use of a mixture of lidocaine and prilocaine and composition for tumescent local anesthesia |
| 03/12/2003 | EP1290187A2 Humain kinases |
| 03/12/2003 | EP1289992A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 03/12/2003 | EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors |
| 03/12/2003 | EP1289951A1 Growth hormone secretagogues |
| 03/12/2003 | EP1289518A2 Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent |
| 03/12/2003 | EP0895478B1 Component b as cicatrizant |
| 03/12/2003 | CN1401375A Medicine for preventing and treating intestinal adhesion in abdominal operation, and preparing method thereof |
| 03/11/2003 | US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/06/2003 | WO2003018756A2 Methods for preparing purified prostaglandin e synthase |
| 03/06/2003 | WO2003018033A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 03/06/2003 | US20030044452 Composition for topical administration |
| 03/06/2003 | US20030044397 In digestable carrier; therapy for liver disorders |
| 02/27/2003 | WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | WO2003015768A2 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 02/27/2003 | WO2003004098A8 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 02/27/2003 | WO2002068383A3 Thiol-modified hyaluronan |
| 02/27/2003 | WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 02/27/2003 | US20030040523 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 02/27/2003 | CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/26/2003 | EP1284743A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 02/26/2003 | EP1284742A2 Biological joint lubricant composition and method of applying |
| 02/26/2003 | EP0799055B1 Selective and non-invasive visualization or treatment of vasculature |
| 02/26/2003 | CN1399573A Use of phthalazine derivatives |
| 02/21/2003 | WO2002016328A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2420208A1 Biphenyl derivatives and their use as integrin inhibitors |
| 02/20/2003 | WO2003013477A1 Drug release system for controlled therapy |
| 02/20/2003 | CA2456706A1 Drug release system for controlled therapy |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1397554A Novel N-benzyl diethylenediamine compound, its prepn. process and medicinal compsns. contg. them |
| 02/18/2003 | US6521456 Gene therapy for cancer; treating viral infections, nervous system disorders, graft rejection, and monogenic or polygenic disorders |
| 02/18/2003 | US6521414 Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1 |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003011313A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/13/2003 | CA2456092A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282439A1 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR |
| 02/12/2003 | EP1075284B1 The use of a vital dye for facilitating surgical procedures for vitreo-retinal surgery |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/06/2003 | WO2000050040A8 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 02/06/2003 | US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280566A2 Growth factor modified protein matrices for tissue engineering |
| 02/05/2003 | CN1395558A Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515016 Treating or preventing multiple sclerosis, by administering an antimicrotubule agent; treating various other inflammatory diseases |
| 02/04/2003 | US6514534 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008374A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007686A2 Use of copper chelators to inhibit the inactivation of protein c |
| 01/30/2003 | US20030021769 Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | CA2452322A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/29/2003 | EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |